Relugolix Beneficial for Prostate Cancer Patients Undergoing Radiotherapy
Short- or longer-term relugolix achieves sustained castration in patients with localized and advanced prostate cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.